News FDA Green Lights Eylea for DME by MedPage Today • 2014/07/31 • 0 Comments (MedPage Today) -- The FDA has approved the vascular endothelial growth factor inhibitor aflibercept (Eylea) for diabetic macular edema, drugmaker Regeneron announced.